
Value of SOX1 and PAX1 Gene Methylation Detection in Secondary Triage of High-Grade Cervical Lesions
Yanping GUO, Qing YANG, Shirui WANG, Simin LI, Boyang YU, Xiaofeng YANG
Acta Academiae Medicinae Sinicae ›› 2024, Vol. 46 ›› Issue (3) : 329-333.
Abbreviation (ISO4): Acta Academiae Medicinae Sinicae
Editor in chief: Xuetao CAO
Value of SOX1 and PAX1 Gene Methylation Detection in Secondary Triage of High-Grade Cervical Lesions
Objective to evaluate the value of SOX1 and PAX1 gene methylation detection in the secondary triage of high-grade cervical lesions.Methods Exfoliated cervical cells were collected from 122 patients tested positive for human papilloma virus(HPV)and subjected To thin-prep cytologic test(TCT)and SOX1/PAX1 gene methylation tests.Results the HPV test combined with TCT showed the sensitivity of 95.24%and the specificity of 23.75%for detecting cervical intraepithelial neoplasia(CIN)grade 2 and above(CIN2+).After the addition of the SOX1/PAX1 gene methylation detection in secondary triage,the sensitivity for detecting CIN2+was 83.33%,which had no statistically significant difference from the sensitivity of TCT combined with HPV test(P=0.078).However,the specificity reached 77.50%,which was significantly higher than that of HPV test combined with TCT(P<0.001).the SOX1/PAX1 gene methylation level in the CIN2+group was higher than those in the normal cervical tissue and the CIN1 group(P<0.001).the cut-off values of SOX1 and PAX1 gene methylation for CIN2+detection were-11.81 and-11.98,respectively.Conclusion Adding the detection of SOX1/PAX1 gene methylation in secondary triage significantly improves the efficiency and accuracy of CIN2+detection。
SOX1 / PAX1 / methylation / cervical lesion
[1] |
郑荣寿, 张思维, 孙可欣, 等. 2016年中国恶性肿瘤流行情况分析[J]. 中华肿瘤杂志, 2023, 45(3):212-220.DOI:10.3760/cma.j.cn112152-20220922-00647.
|
[2] |
|
[3] |
|
[4] |
王攀, 赵洪林, 任凡, 等. 表观遗传学在恶性肿瘤发生发展和治疗中的新进展[J]. 中国肺癌杂志, 2020, 23(2):91-100.DOI:10.3779/j.issn.1009-3419.2020.02.04.
|
[5] |
刘贽, 席金瓯, 夏剑波. 抑癌基因DNA异常甲基化与宫颈癌研究进展[J]. 微循环学杂志, 2019, 29(3):75-78.DOI:10.3969/j.issn.1005-1740.2019.03.017.
|
[6] |
|
[7] |
|
[8] |
|
[9] |
余艳琴, 郝金奇, 徐慧芳, 等. 宫颈癌综合预防和控制的应用和前景[J]. 中国医学科学院学报, 2020, 42(4):535-539.DOI:10.3881/j.issn.1000-503X.11370.
|
[10] |
|
[11] |
[12] |
|
[13] |
程媛, 魏丽惠, 王建六. PAX1基因及其甲基化在宫颈癌作用的分子机制研究进展[J]. 实用妇产科杂志, 2016, 32(11):823-825.
|
[14] |
|
[15] |
|
[16] |
|
[17] |
谌媛媛, 李静. 宫颈脱落细胞中PAX1和SOX1基因甲基化对宫颈癌实验诊断的临床研究[J]. 现代检验医学杂志, 2022, 37(6):46-51.DOI:10.3969/j.issn.1671-7414.2022.06.009.
|
[18] |
|
[19] |
|
/
〈 |
|
〉 |